Dr Timothy Crook, Consultant Medical Oncologist

Dr Timothy Crook

Consultant Medical Oncologist

Book online
|

Dr Timothy Crook MBBS, BSc, PhD, CCT(Med Onc)

Consultant Medical Oncologist

MBBS, BSc, PhD, CCT(Med Onc)

Dr Timothy Crook

Consultant Medical Oncologist MBBS, BSc, PhD, CCT(Med Onc)

Book online
|
MBBS, BSc, PhD, CCT(Med Onc)

Areas of expertise

  • Chemotherapy
  • Bladder cancer
  • Breast disease
  • Kidney cancer
  • Skin cancer

Recommendations for Dr Crook

These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.

Recommended by:

  • byMr Neill Patani, Consultant Oncoplastic & Reconstructive Breast Surgeon

    Dr Timothy Crook is a specialist in medical oncology with research interests in personalised oncology and novel treatments for resistant cancers. He is a valued member of the London Breast Institute multi-disciplinary team.

  • byMr Neill Patani, Consultant Oncoplastic & Reconstructive Breast Surgeon

    Dr Timothy Crook is a specialist in medical oncology with research interests in personalised oncology and novel treatments for resistant cancers. He is a valued member of the London Breast Institute multi-disciplinary team.

  • Address

    • LOC at Chelsea

      102 Sydney Street, Chelsea, London, SW3 6NJ

    • LOC - Leaders in Oncology Care

      95-97 Harley Street, London, W1G 6AF

    • Sydney Street Outpatients and Diagnostics Centre

      102 Sydney Street, London, SW3 6NJ

    • The Harley Street Clinic

      35 Weymouth Street, London, W1G 8BJ

    • The Princess Grace Hospital

      42-52 Nottingham Place, London, W1U 5NY

    • The Wellington Hospital

      Wellington Place, St John's Wood, London, NW8 9LE

    About Dr Timothy Crook

    GMC number: 4735788

    Year qualified: 2000

    Place of primary qualification: University of London

    Dr Timothy Robert Crook is a consultant in medical oncology who works at The Princess Grace Hospital, The Harley Street Clinic, The Wellington Hospital, and LOC.

    Dr Crook specialises in the treatment and management of bladder cancer, breast disease, kidney cancer, and skin cancer. His expertise extends to the administration of chemotherapy and comprehensive oncology care. With a profound understanding of these conditions, he is dedicated to providing personalised treatment plans tailored to each patient's unique needs.

    In his role, Dr Crook is involved in diagnosing and treating a wide range of oncological conditions. He is particularly skilled in the latest chemotherapy protocols and advanced therapeutic techniques. His commitment to staying at the forefront of medical advancements ensures that his patients receive the highest standard of care.

    Dr Crook's professional interests include researching new treatment modalities and improving patient outcomes in oncology. He is passionate about educating his patients and their families, ensuring they are well-informed about their conditions and treatment options.

    Throughout his career, Dr Crook has been recognised for his compassionate approach and dedication to his patients. His work not only focuses on treating the disease but also on supporting the overall well-being of his patients.

    Dr Timothy Robert Crook continues to contribute significantly to the field of medical oncology, making a positive impact on the lives of those he treats.

    Areas of expertise

    • Medical Oncology
    • Immunotherapy
    • Breast Cancer
    • Melonoma
    • Renal cancer
    • Urological oncology

    Professional memberships

    European Society for Medical Oncology
    General Medical Council

    Articles by Dr Timothy Crook

    102pencyclopedic tumour analysis (eta) guided combination regimens of hormone receptor antagonists with other systemic agents for treatment of refractory cancers

    111pmtor inhibitors in combination regimens guided by encyclopedic tumour analysis show superior outcomes compared to monotherapy in refractory cancers

    Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers: results from the resilient trial

    Multi-analyte liquid biopsies for treatment guidance in advanced refractory cancers: findings of the liquid impact trial

    Clinical utility of circulating tumor-associated cells to predict and monitor chemo-response in solid tumors

    Hallmark circulating tumor-associated cell clusters signify 230 times higher one-year cancer risk

    Circulating ensembles of tumor associated cells: a redoubtable new systemic hallmark of cancer

    Evaluation of circulating tumor cell clusters for pan-cancer noninvasive diagnostic triaging